Evidence map›Paper›PMID 27514366›Full record

SynthesisBMC research notes2016

Systematic review of interventions for depression and anxiety in persons with inflammatory bowel disease.

Kirsten M Fiest, Charles N Bernstein, John R Walker, Lesley A Graff, Carol A Hitchon, Christine A Peschken, Ryan Zarychanski, Ahmed Abou-Setta, Scott B Patten, Jitender Sareen and 4 more

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMC research notes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
9.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Comorbid anxiety-like behavior in a rat model of colitis is mediated by an upregulation of corticolimbic fatty acid amide hydrolase.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Article
  9. Comorbid depression in medical diseases.Nature reviews. Disease primers · 2020
    Review
  10. Review
  11. Review
  12. Inflammatory Bowel Disease Patient Experiences with Psychotherapy in the Community.Journal of clinical psychology in medical settings · 2019
    Article
  13. Article
  14. Anxiety, depression, and inflammation after restorative proctocolectomy.International journal of colorectal disease · 2018
    Article
  15. Addressing Mental Health in Persons with IBD.Journal of the Canadian Association of Gastroenterology · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Kirsten M FiestDepartment of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, 820 Sherbrook Street, Winnipeg, R3A1R9, Canada. kfiest@hsc.mb.ca.
Charles N BernsteinDepartment of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, 820 Sherbrook Street, Winnipeg, R3A1R9, Canada.
John R WalkerDepartment of Clinical Health Psychology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, 771 Bannatyne Avenue, Winnipeg, R3E3N4, Canada.
Lesley A GraffDepartment of Clinical Health Psychology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, 771 Bannatyne Avenue, Winnipeg, R3E3N4, Canada.
Carol A HitchonDepartment of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, 820 Sherbrook Street, Winnipeg, R3A1R9, Canada.
Christine A PeschkenDepartment of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, 820 Sherbrook Street, Winnipeg, R3A1R9, Canada.
Ryan ZarychanskiDepartment of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, 820 Sherbrook Street, Winnipeg, R3A1R9, Canada.
Ahmed Abou-SettaGeorge and Fay Yee Centre for Health Care Innovation, University of Manitoba, 820 Sherbrook Street, Winnipeg, R3A1R9, Canada.
Scott B PattenDepartments of Community Health Sciences and Psychiatry, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, T2N4Z6, Canada.
Jitender SareenDepartment of Psychiatry, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, 771 Bannatyne Avenue, Winnipeg, R3E3N4, Canada.
James BoltonDepartment of Psychiatry, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, 771 Bannatyne Avenue, Winnipeg, R3E3N4, Canada.
Alexander SingerDepartment of Family Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, 770 Bannatyne Avenue, Winnipeg, R3E0W3, Canada.
Ruth Ann MarrieDepartment of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, 820 Sherbrook Street, Winnipeg, R3A1R9, Canada.
CIHR Team “Defining the burden and managing the effects of psychiatric comorbidity in chronic immunoinflammatory disease”
University of Manitoba · CAGeorge & Fay Yee Centre for Healthcare Innovation · CAHealth Sciences Centre · CAUniversity of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDepression and anxiety are common in inflammatory bowel disease (IBD) and can affect disease outcomes, including quality of life and success of disease treatment. Successful management of psychiatric comorbidities may improve outcomes, though the effectiveness of existing treatments in IBD is unknown.

methodsWe searched multiple online databases from inception until March 25, 2015, without restrictions on language, date, or location of publication. We included controlled clinical trials conducted in persons with IBD and depression or anxiety. Two independent reviewers reviewed all abstracts and full-text articles and extracted information including trial and participant characteristics. We also assessed the risk of bias.

resultsOf 768 unique abstracts, we included one trial of pharmacological anxiety treatment in IBD (48 participants), which found an improvement in anxiety symptoms (p < 0.001). There was a high risk of bias in this trial. We found no controlled clinical trials on the treatment of depression in persons with IBD and depression and no controlled clinical trials reporting on psychological interventions for anxiety or depression in IBD.

conclusionsOnly one trial examined an intervention for anxiety in adults with IBD and no trials studied depression in adults with IBD. The level of evidence is low because of the risk of bias and limited evidence.

Indexed as

AnxietyDepressionHumansInflammatory Bowel DiseasesPublication BiasTreatment OutcomeAnxietyDepressionInflammatory bowel diseaseSystematic review

Identifiers

PMID27514366
PMCPMC4982207
OpenAlexW2508824392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.